Gliminyle MV3 Plus Tablet is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus. Type 2 diabetes is a chronic or lifelong condition that affects the way your body processes glucose. The blood glucose level increases and causes symptoms such as frequent urination, increased thirst, and increased hunger; hence, people with type 2 diabetes either do not produce enough insulin or, if at all the insulin is produced, it is unable to perform its function in the body (insulin resistance). 

Gliminyle MV3 Plus Tablet is a combination of three antidiabetic drugs: Glimepiride, Metformin and Voglibose. Glimepiride, which is a 'sulfonylurea', acts by increasing the amount of insulin released by the pancreas. Together, these prevent the blood glucose levels from rising to very high levels, thus keeping your diabetes under control.

Gliminyle MV3 Plus Tablet should be taken with food to avoid an upset stomach. Based on your medical condition, your doctor will decide for how long you need to take Gliminyle MV3 Plus Tablet . Gliminyle MV3 Plus Tablet may cause certain common side effects such as hypoglycaemia (low blood glucose levels), taste change, nausea, diarrhoea, stomach pain, headache, and upper respiratory symptoms. Most of these side effects do not require medical attention and will resolve gradually over time; however, if you experience these side effects persistently, consult your doctor.

Do not stop taking Gliminyle MV3 Plus Tablet without consulting your doctor, as abrupt stopping may increase your sugar levels, which could further increase the risk of eyesight loss (retinopathy), kidney (nephropathy) and nerve damage (neuropathy). Gliminyle MV3 Plus Tablet should not be taken if you have type 1 diabetes mellitus or severe kidney or liver disease. Please inform your doctor if you have any type of heart disease, are planning to get pregnant or are breastfeeding.

Gliminyle MV3 Plus Tablet contains Glimepiride, Metformin and Voglibose. Glimepiride, which is a 'sulfonylurea', acts by increasing the amount of insulin released by the pancreas. Metformin, which is a 'biguanide', acts by lowering the glucose production in the liver, delaying glucose absorption from the intestines and increasing the body's response to insulin. Voglibose, which is an 'alpha-glucosidase inhibitor', prevents the breakdown of complex sugars into simple sugars such as glucose in the intestine. Gliminyle MV3 Plus Tablet prevents the blood glucose levels from rising to very high levels, thus keeping your diabetes under control. Gliminyle MV3 Plus Tablet also helps to prevent serious complications of diabetes such as kidney damage (Diabetic Nephropathy), blindness (Diabetic Retinopathy), loss of sensation in your hands and feet (Diabetic Neuropathy), Gliminyle MV3 Plus Tablet also helps to reduce your chance of having a heart attack or stroke. Being a combination of three drugs, Gliminyle MV3 Plus Tablet  reduces the need to take multiple pills and hence makes it easier to remember to take the drugs.

Some diabetic patients taking Gliminyle MV3 Plus Tablet may develop a rare but serious condition called lactic acidosis. In this condition, too much lactic acid accumulates in the blood. So, your liver and kidney's proper functioning is required for the elimination of excess lactic acid from the blood. You should not take Gliminyle MV3 Plus Tablet if you have kidney disease, as measured by a blood test. Gliminyle MV3 Plus Tablet may lower vitamin B12 levels, so try to have blood tests annually blood and vitamins. Gliminyle MV3 Plus Tablet , when used with or without insulin, has the tendency to extremely lower the blood sugar level. So, the doctor may lower the dose of insulin. Gliminyle MV3 Plus Tablet may lower your thyroid-stimulating hormone (TSH), so an annual check-up of TSH is suggested.